Cite
MLA Citation
Shinya Ohata et al.. “Bone Marrow Infiltration Is a Distinctive Risk Factor for Rituximab Infusion-Related Reactions in CD20-Positive B-Cell Non-Hodgkin Lymphoma.” Advances in hematology, vol. 2022, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100152261796.0x000038